400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2020-08-26
疾病筛查产品开发商
医药研发/制造
化学&生物药
富达国际;
富达国际;
Janus Henderson Investors;
Janus Henderson Investors;
Farallon Capital Management;
Rock Springs Capital;
鱼鹰资管;
EcoR1 Capital;
Catalio Capital Management;
Colorectal Cancer Alliance;
RA Capital;
T. Rowe Price;
BrightEdge Ventures;
Sands Capital Ventures;
Andreessen Horowitz;
DCVC Bio;
GV;
Kaiser Permanente Ventures;
诺华;
Polaris Partners;
Roche Venture Fund;
Soleus Capital;
Section 32;
Perceptive Advisors;
Bain Capital
药市场透视2026-06-16
罕见病信息网2026-06-15
药筛2026-06-15
求实药社2026-06-15
GLP1减重宝典2026-06-15
亚太易和2026-06-15
synbio深波2026-06-15
细胞与基因治疗领域2026-06-15
GMP行业药文2026-06-15
生物技术小编2026-06-15